US Patent and Trademark Office to hear patent challenge over experimental seizure treatment
The US Patent and Trademark Office (USPTO) is taking a second look at a patent it granted Ovid Therapeutics around methods for treating seizures following …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
